Cargando…
1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454346/ http://dx.doi.org/10.1016/j.annonc.2021.08.1584 |
| _version_ | 1784570468469047296 |
|---|---|
| author | Felip, E. Hernandez, A. Notario, L. Cucurull, M. Quirant, B. Saigí, M. Gómez-Castellà, R. Estevez-Macas, E. Fonollosa, S. Coll Bertral, P. Torres Costa, E. Carcereny Domenech, M. Estival, A. Paradís, A. López Badía, A. Pous Marín, M. Romeo Bueno, M.T. Moran |
| author_facet | Felip, E. Hernandez, A. Notario, L. Cucurull, M. Quirant, B. Saigí, M. Gómez-Castellà, R. Estevez-Macas, E. Fonollosa, S. Coll Bertral, P. Torres Costa, E. Carcereny Domenech, M. Estival, A. Paradís, A. López Badía, A. Pous Marín, M. Romeo Bueno, M.T. Moran |
| author_sort | Felip, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454346 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543462021-09-21 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine Felip, E. Hernandez, A. Notario, L. Cucurull, M. Quirant, B. Saigí, M. Gómez-Castellà, R. Estevez-Macas, E. Fonollosa, S. Coll Bertral, P. Torres Costa, E. Carcereny Domenech, M. Estival, A. Paradís, A. López Badía, A. Pous Marín, M. Romeo Bueno, M.T. Moran Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454346/ http://dx.doi.org/10.1016/j.annonc.2021.08.1584 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Felip, E. Hernandez, A. Notario, L. Cucurull, M. Quirant, B. Saigí, M. Gómez-Castellà, R. Estevez-Macas, E. Fonollosa, S. Coll Bertral, P. Torres Costa, E. Carcereny Domenech, M. Estival, A. Paradís, A. López Badía, A. Pous Marín, M. Romeo Bueno, M.T. Moran 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine |
| title | 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine |
| title_full | 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine |
| title_fullStr | 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine |
| title_full_unstemmed | 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine |
| title_short | 1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine |
| title_sort | 1591p immune response after vaccination against sars-cov-2 in lung cancer (lc) patients (p). prospective study in the medical oncology department at the catalan institute of oncology-badalona, spain: covid-lung vaccine |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454346/ http://dx.doi.org/10.1016/j.annonc.2021.08.1584 |
| work_keys_str_mv | AT felipe 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT hernandeza 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT notariol 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT cucurullm 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT quirantb 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT saigim 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT gomezcastellar 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT estevezmacase 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT fonollosascoll 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT bertralptorres 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT costaecarcereny 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT domenechm 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT estivala 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT paradisalopez 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT badiaapous 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT marinmromeo 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine AT buenomtmoran 1591pimmuneresponseaftervaccinationagainstsarscov2inlungcancerlcpatientspprospectivestudyinthemedicaloncologydepartmentatthecatalaninstituteofoncologybadalonaspaincovidlungvaccine |